| 6 | 0 | 65 |
| 下载次数 | 被引频次 | 阅读次数 |
目的 探究动脉瘤性蛛网膜下腔出血(aSAH)经血管介入栓塞术治疗的效果。方法 采用随机数字表法将前瞻性选取的南充市高坪区人民医院的aSAH患者80例,分为观察组和对照组,两组患者均在2020年1月至2024年12月于本院治疗,每组40例。观察组行血管介入栓塞术,对照组行颅内动脉瘤夹闭术。记录两组手术时长、术中出血量,比较两组术前、术后3 d血清免疫球蛋白G(IgG)、免疫球蛋白M(IgM)、免疫球蛋白A(IgA)、高迁移率组蛋白B1(HMGB1)、可溶性细胞间黏附因子-1(sICAM-1)、可溶性血管细胞黏附因子-1(s VCAM-1),统计两组术后7 d并发症发生率和术后8周预后情况。结果 观察组手术时长、术中出血量均低于对照组(P<0.05)。术后3 d,两组IgG、IgM、IgA、HMGB1、sICAM-1、sVCAM-1水平较术前降低(P<0.05);但观察组IgG、IgM、IgA相比对照组较高,HMGB1、sICAM-1、sVCAM-1相比对照组较低(P<0.05)。观察组术后7 d并发生发生率较对照组低(P<0.05)。观察组术后8周格拉斯哥预后量表(GOS)评分优于对照组(P<0.05)。结论 aSAH患者经血管介入栓塞术治疗对免疫功能的抑制程度更轻,在降低炎症反应、减少并发症的发生和改善短期预后方面具有明显的优势。
Abstract:Objective To explore the effects vascular interventional embolization treatment with aneurysmal subarachnoid hemorrhage(aSAH).Methods Eighty patients with aSAH from Gaoping District People's Hospital were prospectively selected and divided into an observation group and a control group using a random number table method.Both groups were treated from January 2020 to December 2024,with 40 patients in each group.The observation group underwent vascular intervention embolization,while the control group underwent intracranial aneurysm clipping surgery.Record the duration of two sets of surgeries and the amount of intraoperative bleeding.The serum levels of immunoglobulin G(IgG),immunoglobulin M(IgM),immunoglobulin A(IgA),high mobility group protein B1(HMGB1),soluble intercellular adhesion molecular-1(sICAM-1),and soluble vascular cell adhesion factor-1(sVCAM-1) between two groups before and3 days after surgery,and calculate the incidence of complications at 7 days after surgery and the prognosis at 8 weeks after surgery were compared.Results The observation group had lower surgical duration and intraoperative bleeding compared to the control group(P<0.05).Compared with pre-operation,3 days after surgery,IgG,IgM,IgA,HMGB1,sICAM-1,and sVCAM-1 levels decreased(P<0.05).However,after surgery,the observation group had higher levels of IgG,IgM,and IgA compared to the control group,while HMGB1,sICAM-1,and sVCAM-1 were lower compared to the control group(P<0.05).Compared with the control group,there were significant reductions in the incidence of postoperative complications in the observation group 7 days after surgery(P<0.05).The Glasgow outcome scale(GOS) score was better in the observation group than that of the control group 8 weeks after surgery(P<0.05).Conclusions The degree of immune suppression in aSAH patients treated with vascular interventional embolization is lighter,which has significant advantages in reducing inflammatory reactions,minimizing the occurrence of complications,and improving short-term prognosis.
[1]冯佳慧.炎症标志物与动脉瘤性蛛网膜下腔出血后急性脑积水发生相关性研究[D].长春:吉林大学,2024.
[2]廖磊,李明浩,张辉.血清Caspase-8、sICAM-1表达与动脉瘤性蛛网膜下腔出血患者介入栓塞术后脑血管痉挛的相关性分析及预测价值[J].中国实验诊断学,2024,28(10):1140-1144.
[3]李泽新,王璐,庞永斌.血清NGB联合全身免疫炎症指数对动脉瘤性蛛网膜下腔出血患者迟发性脑缺血的预测价值[J].中国实用神经疾病杂志,2024,27(12):1487-1492.
[4]胡慧宇. HMGB1和sRAGE在动脉瘤性蛛网膜下腔出血患者脑脊液中的表达及其临床意义[D].太原:山西医科大学,2023.
[5]王楠斐,张小军,陈飞军,等.血管介入栓塞术和显微瘤颈夹闭术治疗动脉瘤性蛛网膜下腔出血的有效性及安全性[J].中国当代医药,2024,31(23):58-61.
[6]徐跃峤,王宁,胡锦,等.重症动脉瘤性蛛网膜下腔出血管理专家共识(2015)[J].中国脑血管病杂志,2015(4):215-225.
[7]McMillan T,Wilson L,Ponsford J,et al. The Glasgow Outcome Scale-40 years of application and refinement[J].Nat Rev Neurol,2016,12(8):477-485.
[8]万腾,吴晓凡,李靖.血管介入栓塞术治疗动脉瘤性蛛网膜下腔出血疗效及对患者血清高迁移率族蛋白B1、血清可溶性细胞间黏附因子-1、可溶性血管细胞黏附因子-1的影响[J].陕西医学杂志,2025,54(1):80-83.
[9]王爱珠,何珠茹,曾维培,等.血管栓塞介入和颅内夹闭术治疗世界神经外科联盟Ⅳ~Ⅴ级动脉瘤性蛛网膜下腔出血的回顾性队列研究[J].临床与病理杂志,2022,42(12):2912-2917.
[10]董文涛,杨帆,陈俊良,等.颅内介入栓塞术治疗高分级动脉瘤性蛛网膜下腔出血对症状性脑血管痉挛及神经功能的影响[J].中国微侵袭神经外科杂志,2023,27(12):146-149.
[11]周长清,刘浩,张德明,等.显微外科夹闭与血管内介入栓塞治疗动脉瘤性蛛网膜下腔出血的疗效比较[J].川北医学院学报,2022,37(2):162-165.
[12]陈峰林.炎症因子、免疫细胞与颅内动脉瘤形成和破裂的关系:两样本孟德尔随机化研究[D].长春:吉林大学,2024.
[13]庞尊钊,陈艳.血管介入栓塞术在治疗动脉瘤性蛛网膜下腔出血中的有效性及安全性研究[J].系统医学,2025,10(6):77-80.
[14]曹晓磊,顾倩,邵晶.动脉瘤夹闭与血管内弹簧圈栓塞治疗动脉瘤性蛛网膜下腔出血疗效观察[J].海南医学,2023,34(18):2636-2640.
[15]李栋,赵志远,翟延青,等.血管介入栓塞术治疗动脉瘤性蛛网膜下腔出血的疗效及对患者血管内皮功能的影响[J].山东医药,2023,63(4):53-55.
[16]黎莎,张占伟,胡烨,等.术前格拉斯哥昏迷量表评分、白蛋白与纤维蛋白原比值与动脉瘤性蛛网膜下腔出血患者术后转归关系研究[J].陕西医学杂志,2025,54(2):209-213.
基本信息:
DOI:10.15912/j.issn.1671-8194.2026.04.001
中图分类号:R743.35
引用信息:
[1]唐剑,何昌蓉,何凌.血管介入栓塞术治疗对动脉瘤性蛛网膜下腔出血患者的影响[J].中国医药指南,2026,24(04):1-4.DOI:10.15912/j.issn.1671-8194.2026.04.001.
基金信息:
南充市2023年市级科技项目(23YYJCYJ0077)
2026-02-10
2026-02-10